Giada Scantamburlo

Giada Scantamburlo

Auto-generated profile, based on publicly available information

Giada Scantamburlo

PharmGenetix GmbH Niederalm Austria

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2024 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
ALAlec W.R. Langlois
Alec W.R. Langlois
MCMeghan J. Chenoweth
Meghan J. Chenoweth
DTDavid Twesigomwe
David Twesigomwe
GSGiada Scantamburlo
Giada Scantamburlo
MWMichelle Whirl-Carrillo
Michelle Whirl-Carrillo
AGAndrea Gaedigk
Andrea Gaedigk
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the human CYP2A gene locus containing the highly polymorphic CYP2A6 gene. CYP2A6 plays a role in the metabolism of nicotine and various drugs. Thus, genetic variation can substantially contribute to the function of this enzyme and associated efficacy and safety. This GeneFocus provides an overview of the clinical significance of CYP2A6, including its genetic variation and function. We also highlight and discuss caveats in the identification and characterization of allelic variation of this complex pharmacogene, a prerequisite for accurate genotype determination and prediction of phenotype status.

24 March 2017 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
GSGiada Scantamburlo
Giada Scantamburlo
SVSimone Vanoni
Simone Vanoni
Silvia DossenaSilvia Dossena
Silvia Dossena
SSSelma M. Soyal
Selma M. Soyal
EBEmanuele Bernardinelli
Emanuele Bernardinelli
CNCharity Nofziger
Charity Nofziger
Pendrin is upregulated in bronchial epithelial cells following IL-4 stimulation via binding of STAT6 to an N4 GAS motif. Basal CpG methylation of the pendrin promoter is cell-specific. We studied if a correlation exists between IL-4 sensitivity and the CpG methylation status of the pendrin promoter in human bronchial epithelial cell models. Methods: Real-time PCR and pyrosequencing were used to respectively quantify pendrin mRNA levels and methylation of pendrin promoter, with and without IL-4 stimulation, in healthy and diseased primary HBE cells, as well as NCI-H292 cells. Results: Increases in pendrin mRNA after IL-4 stimulation was more robust in NCI-H292 cells than in primary cells. The amount of gDNA methylated varied greatly between the cell types. In particular, CpG site 90 located near the N4 GAS motif was highly methylated in the primary cells. An additional CpG site (90bis), created by a SNP, was found only in the primary cells. IL-4 stimulation resulted in dramatic demethylation of CpG sites 90 and 90bis in the primary cells. Conclusions: IL-4 induces demethylation of specific CpG sites within the pendrin promoter. These epigenetic alterations are cell type specific, and may in part dictate pendrin mRNA transcription.